---
url: 'https://wagner.nyu.edu/education/capstone/projects/medication-assisted-treatment-new-york-and-new-jersey-drug-courts'
title: 'Medication-Assisted Treatment in New York and New Jersey Drug Courts'
author:
  name: nyu81
  url: 'https://wagner.nyu.edu/users/nyuwanger'
date: '2014-12-08T15:33:43+00:00'
updated: '2022-09-03T03:53:35+00:00'
type: capstone
summary: 'The Legal Action Center (LAC) is a nonprofit organization that advocates for individuals who have experienced discrimination due to addiction, HIV/AIDS, or a criminal record. Working within federal and state health reforms, the LAC has made recent efforts to promote the availability of Medication-Assisted Treatment (MAT) to improve the health of persons in the New York and New Jersey criminal justice systems. Opioid addiction is typically treated through a multi-faceted approach involving a combination of MAT, behavioral therapies, and detoxification.'
tags:
  - 'Health Management and Policy'
  - '3870'
  - CAP-GP
published: true
---
#  Medication-Assisted Treatment in New York and New Jersey Drug Courts 

Client

Legal Action Center

 

Faculty

Charles Brecher

 

Team

Jane Dalugdugan, Grace Del Re, Rosemary Dodemaide, Jessie Hole

 

The Legal Action Center (LAC) is a nonprofit organization that advocates for individuals who have experienced discrimination due to addiction, HIV/AIDS, or a criminal record. Working within federal and state health reforms, the LAC has made recent efforts to promote the availability of Medication-Assisted Treatment (MAT) to improve the health of persons in the New York and New Jersey criminal justice systems. Opioid addiction is typically treated through a multi-faceted approach involving a combination of MAT, behavioral therapies, and detoxification. Despite strong evidence supporting the efficacy of MAT, drug courts do not always offer it. The Capstone team was charged with conducting a comprehensive review of existing MAT practices and policies in New York and New Jersey drug courts. The team conducted a literature review, interviewed key informants, and surveyed the drug courts to assess availability of MAT, barriers that prevent utilization of MAT, and identify best practices in MAT administration.